CytomX Therapeutics, Inc. - Common Stock (CTMX)
CUSIP: 23284F105
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 169,491,059
- Total 13F shares
- 34,120,916
- Share change
- -1,474,074
- Total reported value
- $58,688,106
- Put/Call ratio
- 30%
- Price per share
- $1.72
- Number of holders
- 66
- Value change
- -$2,378,087
- Number of buys
- 22
- Number of sells
- 32
Quarterly Holders Quick Answers
What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23284F105:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
3.9%
|
6,595,801
|
$9,959,660 | — | 31 Mar 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.6%
|
6,093,032
|
$9,200,478 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
4,915,053
|
$7,421,730 | — | 31 Mar 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.6%
|
2,653,576
|
$4,006,000 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.1%
|
1,891,386
|
$2,855,993 | — | 31 Mar 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
0.7%
|
1,188,225
|
$1,794,220 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.66%
|
1,123,772
|
$1,696,896 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.57%
|
961,042
|
$1,451,000 | — | 31 Mar 2023 | |
| Bronte Capital Management Pty Ltd. |
13F
|
Company |
0.54%
|
917,754
|
$1,385,809 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.5%
|
850,300
|
$1,284,000 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.43%
|
729,938
|
$1,102,206 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
0.42%
|
705,697
|
$1,065,603 | — | 31 Mar 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.39%
|
668,032
|
$1,008,728 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
642,308
|
$969,885 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.3%
|
516,100
|
$779,311 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.28%
|
467,616
|
$706,100 | — | 31 Mar 2023 | |
| Newtyn Management, LLC |
13F
|
Company |
0.25%
|
425,000
|
$641,750 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.21%
|
347,786
|
$525,156 | — | 31 Mar 2023 | |
| Formidable Asset Management, LLC |
13F
|
Company |
0.19%
|
318,111
|
$480,000 | — | 31 Mar 2023 | |
| Tidal Investments LLC |
13F
|
Company |
0.19%
|
318,111
|
$480,000 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.18%
|
300,841
|
$454,270 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.16%
|
278,677
|
$420,803 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.16%
|
267,476
|
$403,889 | — | 31 Mar 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.15%
|
247,157
|
$373,207 | — | 31 Mar 2023 | |
| Clearline Capital LP |
13F
|
Company |
0.12%
|
196,583
|
$296,841 | — | 31 Mar 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
176,000
|
$265,760 | — | 31 Mar 2023 | |
| Tejara Capital Ltd |
13F
|
Company |
0.09%
|
157,928
|
$238,471 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.09%
|
156,456
|
$236,134 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
151,375
|
$228,577 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.08%
|
134,309
|
$202,807 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
120,000
|
$181,200 | — | 31 Mar 2023 | |
| Congress Park Capital LLC |
13F
|
Company |
0.06%
|
100,200
|
$151,302 | — | 31 Mar 2023 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.05%
|
82,415
|
$124,447 | — | 31 Mar 2023 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.04%
|
73,179
|
$110,500 | — | 31 Mar 2023 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
58,765
|
$88,735 | — | 31 Mar 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
57,055
|
$86,152 | — | 31 Mar 2023 | |
| Amy C. Peterson |
3/4/5
|
EVP, Chief Development Officer |
—
class O/S missing
|
58,433
|
$80,678 | — | 16 Mar 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
53,243
|
$80,000 | — | 31 Mar 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
48,856
|
$73,773 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
45,351
|
$69,000 | — | 31 Mar 2023 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.03%
|
44,730
|
$68,000 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
40,581
|
$61,277 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
40,031
|
$60,447 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
36,152
|
$54,590 | — | 31 Mar 2023 | |
| Carlos Campoy |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
38,224
|
$52,776 | — | 16 Mar 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.02%
|
34,084
|
$51,467 | — | 31 Mar 2023 | |
| Alison L. Hannah |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
31,898
|
$44,042 | — | 19 Jul 2022 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.02%
|
27,100
|
$40,921 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
26,793
|
$40,457 | — | 31 Mar 2023 | |
| Forefront Analytics, LLC |
13F
|
Company |
0.02%
|
26,412
|
$39,884 | — | 31 Mar 2023 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock (CTMX) as of Q2 2023
As of 30 Jun 2023,
CytomX Therapeutics, Inc. - Common Stock (CTMX) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,120,916 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, BVF INC/IL, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, Laurion Capital Management LP, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Bronte Capital Management Pty Ltd., and FMR LLC.
This page lists
66
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
74
Q2 2023 holders
66
Holder diff
-8
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.